In fact, adiponectin has anti-inflammatory and anti-fibrogenic properties and, in steatotic liver, has been showed to ameliorate necroinflammation and steatosis when administered in experimental NASH [85,86]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.